Works by Clisant, Stéphanie

Results: 29

REGOSARC: Regorafenib versus placebo in doxorubicin-refractory soft-tissue sarcoma-A quality-adjusted time without symptoms of progression or toxicity analysis.

Published in:

2017

By:

Berry, Vincent;
Basson, Laurent;
Bogart, Emilie;
Mir, Olivier;
Blay, Jean‐Yves;
Italiano, Antoine;
Bertucci, François;
Chevreau, Christine;
Clisant‐Delaine, Stéphanie;
Liegl‐Antzager, Bernadette;
Tresch‐Bruneel, Emmanuelle;
Wallet, Jennifer;
Taieb, Sophie;
Decoupigny, Emilie;
Cesne, Axel;
Brodowicz, Thomas;
Penel, Nicolas;
Blay, Jean-Yves;
Bertucci, François;
Clisant-Delaine, Stéphanie

Publication type:

journal article

The FREGAT biobank: a clinico-biological database dedicated to esophageal and gastric cancers.

Published in:

2018

By:

Mariette, Christophe;
Renaud, Florence;
Piessen, Guillaume;
Gele, Patrick;
Copin, Marie-Christine;
Leteurtre, Emmanuelle;
Delaeter, Christine;
Dib, Malek;
Clisant, Stéphanie;
Harter, Valentin;
Bonnetain, Franck;
Duhamel, Alain;
Christophe, Véronique;
Adenis, Antoine;
Fregat Working Group;
Clisant, Stéphanie;
Christophe, Véronique

Publication type:

journal article

Low level of baseline circulating VEGF-A is associated with better outcome in patients with vascular sarcomas receiving sorafenib: an ancillary study from a phase II trial.

Published in:

Targeted Oncology, 2014, v. 9, n. 3, p. 273, doi. 10.1007/s11523-013-0299-0

By:

Penel, Nicolas;
Ray-Coquard, Isabelle;
Bal-Mahieu, Christine;
Chevreau, Christine;
Cesne, Axel;
Italiano, Antoine;
Bompas, Emmanuelle;
Clisant, Stéphanie;
Baldeyrou, Brigitte;
Lansiaux, Amélie;
Robin, Yves-Marie;
Bay, Jacques-Olivier;
Piperno-Neumann, Sophie;
Blay, Jean-Yves;
Fournier, Charles

Publication type:

Article

Improvement of the initial management of sarcomas after the dissemination of evidence-based guidelines depends on the primary sarcoma location: a population-based study.

Published in:

BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1225-x

By:

Ligier, Karine;
Maynou, Carlos;
Leroy, Xavier;
Robin, Yves-Marie;
Martin, Philippe;
Clisant, Stéphanie;
Richard, Florence;
Penel, Nicolas

Publication type:

Article

Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial.

Published in:

BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1143-y

By:

Brodowicz, Thomas;
Liegl-Atzwager, Bernadette;
Tresch, Emmanuelle;
Taieb, Sophie;
Kramar, Andrew;
Gruenwald, Viktor;
Vanseymortier, Marie;
Clisant, Stéphanie;
Blay, Jean-Yves;
Le Cesne, Axel;
Penel, Nicolas

Publication type:

Article

Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial.

Published in:

2015

By:

Brodowicz, Thomas;
Liegl-Atzwager, Bernadette;
Tresch, Emmanuelle;
Taieb, Sophie;
Kramar, Andrew;
Gruenwald, Viktor;
Vanseymortier, Marie;
Clisant, Stéphanie;
Blay, Jean-Yves;
Le Cesne, Axel;
Penel, Nicolas

Publication type:

journal article

Clinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: predictors of outcome.

Published in:

2013

By:

Adenis, Antoine;
Tresch, Emmanuelle;
Dewas, Sylvain;
Romano, Olivier;
Messager, Mathieu;
Amela, Eric;
Clisant, Stéphanie;
Kramar, Andrew;
Mariette, Christophe;
Mirabel, Xavier

Publication type:

journal article

Cancer-associated hypercalcemia treated with intravenous diphosphonates: a survival and prognostic factor analysis.

Published in:

2008

By:

Penel N;
Dewas S;
Doutrelant P;
Clisant S;
Yazdanpanah Y;
Adenis A;
Penel, Nicolas;
Dewas, Sylvain;
Doutrelant, Philippe;
Clisant, Stéphanie;
Yazdanpanah, Yazdan;
Adenis, Antoine

Publication type:

journal article

Regorafenib use as a possible cause of intestinal perforation.

Published in:

2013

By:

Adenis, Antoine;
Kotecki, Nuria;
Decanter, Gauthier;
Clisant, Stéphanie;
Penel, Nicolas

Publication type:

Letter

Predictive Value of Clinical Judgment of Tumour Progression in Phase II Trials.

Published in:

PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0052638

By:

Kotecki, Nuria;
Penel, Nicolas;
Adenis, Antoine;
Ferte, Charles;
Clisant, Stéphanie

Publication type:

Article

Sorafenib in patients with progressive epithelioid hemangioendothelioma: A phase 2 study by the French Sarcoma Group (GSF/GETO)

Published in:

2013

By:

Chevreau, Christine;
Le Cesne, Axel;
Ray-Coquard, Isabelle;
Italiano, Antoine;
Cioffi, Angela;
Isambert, Nicolas;
Robin, Yves Marie;
Fournier, Charles;
Clisant, Stéphanie;
Chaigneau, Loic;
Bay, Jacques-Olivier;
Bompas, Emmanuelle;
Gauthier, Eric;
Blay, Jean Y;
Penel, Nicolas

Publication type:

Journal Article

Sorafenib in patients with progressive epithelioid hemangioendothelioma Sorafenib in patients with progressive epithelioid hemangioendothelioma: A phase 2 study by the French Sarcoma Group (GSF/GETO).

Published in:

Cancer (0008543X), 2013, v. 119, n. 14, p. 2639, doi. 10.1002/cncr.28109

By:

Chevreau, Christine;
Le Cesne, Axel;
Ray‐Coquard, Isabelle;
Italiano, Antoine;
Cioffi, Angela;
Isambert, Nicolas;
Robin, Yves Marie;
Fournier, Charles;
Clisant, Stéphanie;
Chaigneau, Loic;
Bay, Jacques‐Olivier;
Bompas, Emmanuelle;
Gauthier, Eric;
Blay, Jean Y.;
Penel, Nicolas

Publication type:

Article

Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use program.

Published in:

2016

By:

Adenis, Antoine;
de la Fouchardiere, Christelle;
Paule, Bernard;
Burtin, Pascal;
Tougeron, David;
Wallet, Jennifer;
Dourthe, Louis-Marie;
Etienne, Pierre-Luc;
Mineur, Laurent;
Clisant, Stéphanie;
Phelip, Jean-Marc;
Kramar, Andrew;
Andre, Thierry

Publication type:

journal article

Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin-folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, randomized phase 2 trial.

Published in:

2016

By:

Messager, Mathieu;
Mirabel, Xavier;
Tresch, Emmanuelle;
Paumier, Amaury;
Vendrely, Véronique;
Dahan, Laetitia;
Glehen, Olivier;
Vasseur, Frederique;
Lacornerie, Thomas;
Piessen, Guillaume;
Hajbi, Farid El;
Robb, William B.;
Clisant, Stéphanie;
Kramar, Andrew;
Mariette, Christophe;
Adenis, Antoine;
El Hajbi, Farid

Publication type:

journal article

First-Line Chemotherapy for Metastatic Esophageal Squamous Cell Carcinoma: Clinico-Biological Predictors of Disease Control.

Published in:

Oncology, 2016, v. 90, n. 2, p. 88, doi. 10.1159/000442947

By:

Kotecki, Nuria;
Hiret, Sandrine;
Etienne, Pierre-Luc;
Penel, Nicolas;
Tresch, Emmanuelle;
François, Eric;
Galais, Marie Pierre;
Ben abdelghani, Meher;
Michel, Pierre;
Dahan, Laetitia;
Ghiringelli, François;
Bedenne, Laurent;
Samalin, Emmanuelle;
Piessen, Guillaume;
Bennouna, Jafaar;
Peugniez, Charlotte;
El Hajbi, Farid;
Clisant, Stéphanie;
Kramar, andrew;
Mariette, Christophe

Publication type:

Article

Frequency of Certain Established Risk Factors in Soft Tissue Sarcomas in Adults: A Prospective Descriptive Study of 658 Cases.

Published in:

Sarcoma, 2008, p. 1, doi. 10.1155/2008/459386

By:

Penel, Nicolas;
Grosjean, Jessica;
Robin, Yves Marie;
Vanseymortier, Luc;
Clisant, Stéphanie;
Adenis, Antoine

Publication type:

Article

Risk Factors for Early Catheter-related Infections in Cancer Patients.

Published in:

Cancer (0008543X), 2007, v. 110, n. 7, p. 1586, doi. 10.1002/cncr.22942

By:

Penel, Nicolas;
Neu, Jean-Charles;
Clisant, Stéphanie;
Hoppe, Helga;
Devos, Patrick;
Yazdanpanah, Yazdan

Publication type:

Article

Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial.

Published in:

2018

By:

Pannier, Diane;
Adenis, Antoine;
Bogart, Emilie;
Dansin, Eric;
Clisant-Delaine, Stéphanie;
Decoupigny, Emilie;
Lesoin, Anne;
Amela, Eric;
Ducornet, Sandrine;
Meurant, Jean-Pierre;
Le Deley, Marie-Cécile;
Penel, Nicolas

Publication type:

journal article

Serum creatine kinase increase in patients treated with tyrosine kinase inhibitors for solid tumors.

Published in:

Medical Oncology, 2012, v. 29, n. 4, p. 3003, doi. 10.1007/s12032-012-0204-1

By:

Adenis, Antoine;
Bouché, Olivier;
Bertucci, François;
Kalbacher, Elsa;
Fournier, Charles;
Cassier, Philippe;
Collard, Olivier;
Bay, Jacques-Olivier;
Italiano, Antoine;
Chevreau, Christine;
Clisant, Stéphanie;
Kramar, Andrew;
Blay, Jean-Yves;
Penel, Nicolas

Publication type:

Article

Dose-Seeking Phase I Trials for Currently Approved Molecular-Targeted Therapies in the USA: The Dose-Limiting Toxicity Definition Issue.

Published in:

Pharmaceutical Medicine, 2016, v. 30, n. 3, p. 143, doi. 10.1007/s40290-016-0138-6

By:

Kotecki, Nuria;
Awada, Ahmad;
Bonneterre, Jacques;
Hebbar, Mohamed;
Adenis, Antoine;
Cortot, Alexis;
Cousin, Sophie;
Clisant, Stéphanie;
Duhamel, Alain;
Penel, Nicolas

Publication type:

Article

Erratum: Prevention of surgical site infection after breast cancer surgery by targeted prophylaxis antibiotic in patients at high risk of surgical site infection. Nicolas P, Yazdan Y, Marie-Pierre C, Stéphanie C, Sylvia G, Jean-Charles N, Danièle L, Charles F, Jacques B. 2007. J Surg Oncol 96:124-129.

Published in:

Journal of Surgical Oncology, 2008, v. 97, n. 5, p. 479, doi. 10.1002/jso.20943

By:

Penel, Nicolas;
Yazdanpanah, Yazdan;
Chauvet, Marie-Pierre;
Clisant, Stéphanie;
Giard, Sylvia;
Neu, Jean-Charles;
Lefebvre, Danièle;
Fournier, Charles;
Bonneterre, Jacques

Publication type:

Article

Prevention of surgical site infection after breast cancer surgery by targeted prophylaxis antibiotic in patients at high risk of surgical site infection.

Published in:

Journal of Surgical Oncology, 2007, v. 96, n. 2, p. 124, doi. 10.1002/jso.20796

By:

Nicolas, Penel;
Yazdan, Yazdanpanah;
Marie-Pierre, Chauvet;
Stéphanie, Clisant;
Sylvia, Giard;
Jean-Charles, Neu;
Danièle, Lefebvre;
Charles, Fournier;
Jacques, Bonneterre

Publication type:

Article

Predictors for establishing recommended phase 2 doses: analysis of 320 dose-seeking oncology phase 1 trials.

Published in:

Investigational New Drugs, 2012, v. 30, n. 2, p. 653, doi. 10.1007/s10637-010-9574-4

By:

Penel, Nicolas;
Duhamel, Alain;
Adenis, Antoine;
Devos, Patrick;
Isambert, Nicolas;
Clisant, Stéphanie;
Bonneterre, Jacques

Publication type:

Article

Circulating thrombospondin 1 level as a surrogate marker in patients receiving cyclophosphamide-based metronomic chemotherapy.

Published in:

2012

By:

Lansiaux, Amélie;
Salingue, Sophie;
Dewitte, Amélie;
Clisant, Stéphanie;
Penel, Nicolas

Publication type:

Report

Nature and subjectivity of dose-limiting toxicities in contemporary phase 1 trials: comparison of cytotoxic versus non-cytotoxic drugs.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1414, doi. 10.1007/s10637-010-9490-7

By:

Penel, Nicolas;
Adenis, Antoine;
Clisant, Stéphanie;
Bonneterre, Jacques

Publication type:

Article

Factual understanding of randomized clinical trials: a multicenter case-control study in cancer patients.

Published in:

Investigational New Drugs, 2011, v. 29, n. 4, p. 700, doi. 10.1007/s10637-009-9315-8

By:

Leroy, Tanguy;
Christophe, Véronique;
Penel, Nicolas;
Antoine, Pascal;
Clisant, Stéphanie

Publication type:

Article

Justification of the starting dose as the main determinant of accrual time in dose-seeking oncology phase 1 trials.

Published in:

Investigational New Drugs, 2010, v. 28, n. 6, p. 839, doi. 10.1007/s10637-009-9317-6

By:

Penel, Nicolas;
Leblond, Pierre;
Lansiaux, Amélie;
Clisant, Stéphanie;
Dansin, Eric;
Adenis, Antoine;
Bonneterre, Jacques

Publication type:

Article

O-Mel-Inib: A Cancéro-pôle Nord-Ouest multicenter phase II trial of high-dose Imatinib mesylate in metastatic uveal melanoma.

Published in:

Investigational New Drugs, 2008, v. 26, n. 6, p. 561, doi. 10.1007/s10637-008-9143-2

By:

Penel, Nicolas;
Delcambre, Corinne;
Durando, Xavier;
Clisant, Stéphanie;
Hebbar, Mohamed;
Negrier, Sylvie;
Fournier, Charles;
Isambert, Nicolas;
Mascarelli, Frédéric;
Mouriaux, Frédéric

Publication type:

Article

HIGH-DOSE <sup>131</sup>I-MIBG THERAPIES IN CHILDREN: FEASIBILITY, PATIENT DOSIMETRY AND RADIATION EXPOSURE TO WORKERS AND FAMILY CAREGIVERS.

Published in:

Radiation Protection Dosimetry, 2017, v. 173, n. 4, p. 395, doi. 10.1093/rpd/ncw030

By:

Cougnenc, Olivier;
Defachelles, Anne-Sophie;
Carpentier, Philippe;
Lervat, Cyril;
Clisant, Stéphanie;
Oudoux, Aurore;
Kolesnikov-Gauthier, Hélène

Publication type:

Article